Vaughan Nelson Investment Management L.P. Lowers Stake in HealthEquity, Inc. (NASDAQ:HQY)

Vaughan Nelson Investment Management L.P. reduced its position in HealthEquity, Inc. (NASDAQ:HQY) by 10.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 758,463 shares of the company’s stock after selling 84,960 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in HealthEquity were worth $72,774,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of HQY. Raymond James Trust N.A. grew its holdings in HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares in the last quarter. UMB Bank n.a. increased its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the last quarter. Truist Financial Corp lifted its stake in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after purchasing an additional 188 shares in the last quarter. Elk River Wealth Management LLC boosted its holdings in shares of HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock valued at $5,417,000 after purchasing an additional 217 shares during the last quarter. Finally, Nicolet Advisory Services LLC grew its position in shares of HealthEquity by 5.8% during the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock valued at $330,000 after purchasing an additional 233 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HQY has been the subject of a number of research reports. JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Royal Bank of Canada upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Bank of America lifted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target for the company. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Stock Down 0.5 %

Shares of HQY opened at $111.52 on Friday. The firm has a market capitalization of $9.66 billion, a P/E ratio of 102.31, a P/E/G ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $113.61. The firm has a fifty day moving average price of $100.97 and a 200-day moving average price of $89.67. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the company earned $0.40 earnings per share. Equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.